OMADA Health CEO Sees Dual‑Trade Tactics: Buys at $5.82, Sells at $20.40 in Same Day 10(b)(5)(1) Plan.

Insider Activity in Focus: OMADA Health’s CEO Buys Amid a Tightly‑Controlled 10(b)(5)(1) Plan

On August 3, 2026, Chief Executive Officer Sean Duffy executed a purchase of 12,944 common shares at a weighted average price of $5.82 under his 10(b)(5)(1) trading plan, bringing his post‑transaction holdings to 424,805 shares. The same day he also sold an equal block of shares at a higher price of $20.40, reducing his holdings to 411,861 shares. These dual transactions are a textbook example of a “buy‑sell” pair that allows insiders to lock in gains while still complying with the timing and price restrictions of a 10(b)(5)(1) plan. The market‑price trade on the day of the filing—$20.18—suggests the CEO is comfortable trading near market value, even though the buy price was substantially lower, reflecting the benefit of a pre‑set price schedule.

What Does This Mean for Investors?

The back‑to‑back buy and sell indicate that Duffy is maintaining a large, liquid stake in OMADA, yet he is also capitalizing on short‑term price movements. For investors, this pattern signals confidence from the top executive but also a willingness to monetize positions. The overall insider buying has increased by roughly 10% over the past quarter, a modest uptick that could be interpreted as a bullish cue, especially when the company’s weekly and monthly performance has been negative. However, the high volatility of OMADA’s stock—peaking at $26.92 last year and sliding to $10.28 in February—reminds stakeholders that insider activity is only one of many factors to consider.

Historical Behavior of CEO Sean Duffy

Duffy’s trade history over the last six months shows a consistent strategy of alternating between option exercise, immediate sale, and periodic purchases. He has frequently used the 10(b)(5)(1) plan to sell large blocks (e.g., 12,942 shares at $22.70 on July 1) while also buying back shares at lower levels (e.g., $5.82 and $8.28). The timing of these transactions often coincides with quarterly earnings releases or significant corporate announcements, suggesting a disciplined approach to liquidity management rather than opportunistic speculation. Moreover, his holdings in family trusts remain static at 851,659 shares, underscoring a long‑term investment horizon.

Company‑Wide Insider Activity

While Duffy’s moves dominate, other key executives have also engaged in sizeable trades. CFO Steven Cook and CAO Craig have both bought and sold shares at comparable price points, indicating that OMADA’s leadership is generally aligned in their views of the company’s trajectory. The aggregate insider buying in the past 30 days totals approximately 15,000 shares, whereas selling exceeds 20,000. This net selling pressure, albeit moderate, could contribute to the current 2.55% weekly decline and a 16.37% monthly slide.

Conclusion

Sean Duffy’s latest transaction—buying and selling a block of OMADA shares under a pre‑approved plan—reinforces his ongoing commitment to the company while also demonstrating a pragmatic use of insider trading windows. For investors, the dual nature of this move offers both a positive signal of executive confidence and a reminder of the inherent volatility in OMADA’s stock. As the market watches the CEO’s subsequent activity, analysts will likely scrutinize whether his buying‑sell strategy will stabilize the share price or simply reflect routine portfolio rebalancing.